macleaya
cordata
willd
r
br
bo
luo
hui
fig
use
treatment
cancer
insect
bite
ringworm
infect
mainland
china
north
america
europ
phytochem
pharmacolog
studi
demonstr
isoquinolin
alkaloid
deriv
cordata
major
activ
compon
thirti
isoquinolin
alkaloid
isol
cordata
fig
includ
chelerythrin
sanguinarin
sanguidimerin
chelidimerin
berberin
coptisin
allocryptopin
protopin
alkaloid
exhibit
broad
spectrum
biolog
activ
antitumor
antiinflammatori
antimicrobi
analges
antioxid
activ
previou
studi
found
cordata
could
count
one
richest
resourc
mainland
china
among
speci
tribe
chelidoniea
also
one
promis
natur
resourc
drug
discoveri
cordata
gain
attent
pharmacognosist
sinc
earli
fig
howev
obscur
molecular
action
hinder
use
drug
develop
although
dock
techniqu
avail
virtual
drug
screen
specif
target
tumor
necrosi
factor
enzym
tace
induc
nitric
oxid
synthas
ino
janusactiv
kinas
dock
approach
virtual
screen
often
comput
expens
studi
aim
investig
compoundtarget
interact
network
isoquinolin
alkaloid
cordata
revers
pharmacophor
databas
screen
technolog
outlin
potenti
action
mechan
figur
show
workflow
studi
structur
bioactiv
isoquinolin
alkaloid
cordata
collect
literatur
review
alkaloid
appli
target
fish
two
pharmacophor
target
databas
pharmadb
hypodb
hit
pharmacophor
model
pick
accord
threshold
predetermin
fit
valu
result
pharmadb
screen
compar
hypodb
screen
analysi
hit
target
associ
pathway
diseas
well
interact
alkaloid
target
action
network
cordata
construct
literatur
retriev
simultan
carri
verifi
find
activ
compon
cordata
collect
databas
literatur
isoquinolin
alkaloid
cordata
bioactiv
list
tabl
shown
fig
alkaloid
divid
three
class
benzo
c
phenanthridin
ben
protoberberin
ber
protopin
pro
base
replac
cring
belong
dihydrobenzo
c
phenanthridin
ndemethyl
subtyp
quaternari
ammonium
base
share
iminium
moieti
cn
remain
two
bisbenzo
c
phenanthridin
bisben
epim
one
anoth
structur
alkaloid
candid
prepar
mol
format
convert
draw
model
energi
minim
softwar
discoveri
studio
ds
develop
bivia
usa
charmm
forc
field
mont
carlobas
conform
analysi
fast
mode
perform
gener
conform
initi
conform
maxim
conform
allow
energi
interv
kcalmol
alkaloid
molecul
rigid
number
conform
compound
much
fewer
henc
total
conform
gener
isoquinolin
alkaloid
pharmacophor
model
repres
seri
common
featur
set
ligand
special
pharmacolog
target
featur
pharmacophor
model
reflect
interact
mode
pharmacophorebas
virtual
screen
altern
dock
fit
compound
panel
pharmacophor
model
deriv
multipl
pharmacolog
target
potenti
target
compound
outlin
autom
ligand
profil
avail
ds
socal
ligand
profil
protocol
softwar
offer
autom
pharmacophorebas
activ
profil
report
studi
default
paramet
ds
use
candid
ligand
three
featur
map
ds
equip
two
avail
pharmacophor
databas
ie
hypodb
pharmadb
hypodb
contain
pharmacophor
model
deriv
complex
structur
well
structur
data
small
bioactiv
organ
molecul
pharmadb
creat
scpdb
wellaccept
data
sourc
structurebas
profil
protocol
scpdb
collect
structur
bind
site
found
protein
data
bank
pdb
bind
site
extract
crystal
structur
complex
protein
caviti
small
molecul
ligand
could
identifi
pharmadb
consist
pharmacophor
deriv
complex
scpdb
dataset
pharmadb
new
updat
pharmacophor
databas
develop
collabor
prof
didier
rognan
target
pharmacophor
model
pharmadb
hypodb
entir
consist
pharmadb
larger
quantiti
target
model
hypodb
fewer
describ
experiment
valid
therefor
studi
pharmadb
employ
target
fish
hypodb
use
valid
result
regard
pharmadb
multipl
pharmacophor
shape
exclud
volum
constraint
gener
protein
target
pharmacophor
shape
constraint
suffix
ad
name
addit
numer
suffix
refer
rank
select
evalu
default
algorithm
ds
studi
best
model
name
employ
ligand
profil
pharmacophor
databas
classif
tree
avail
individu
model
could
select
profil
pharmadb
pharmacophor
model
shape
bind
pocket
select
virtual
screen
default
set
rigid
mode
use
molecular
map
algorithm
molecular
featur
allow
miss
map
ligand
pharmacophor
model
increas
select
minim
interfeatur
distanc
set
parallel
screen
technolog
one
compound
multitud
pharmacophor
model
avail
pipelin
pilot
protocol
number
parallel
process
procedur
set
whole
calcul
carri
workstat
dell
inc
usa
pose
ligand
map
pharmacophor
preserv
seri
targetligand
pair
select
emphasi
examin
select
base
upon
compat
report
pharmacolog
activ
well
tradit
usag
mcordata
refin
carri
molecular
oper
environ
moe
develop
ccg
canada
identifi
bind
mode
energi
minim
carri
conjug
gradient
minim
forc
field
rmsd
kcal
reach
interact
tabl
alkaloid
target
present
ligand
profil
result
target
name
pathway
inform
collect
pdb
kegg
diseas
relat
target
collect
therapeut
target
databas
ttd
http
biddnusedusggroupcjttd
drugbank
http
wwwdrugbankca
databas
compoundtargetpathway
network
gener
cytoscap
cytoscap
consortium
usa
network
node
repres
compound
target
biolog
pathway
edg
link
compoundtarget
targetpathway
repres
relationship
mark
differ
type
line
network
built
basic
paramet
network
comput
analyz
topolog
analysi
interact
network
offer
insight
biolog
relev
connect
pattern
highli
influenti
compound
target
chines
medicin
investig
interact
network
analysi
pharmacolog
network
cordata
three
type
node
fig
alkaloid
node
form
core
network
surround
target
node
target
link
least
one
pathway
total
pathway
node
constitut
outer
layer
network
alkaloid
center
starshap
action
net
except
two
bisbenzo
c
phenanthridin
bisben
link
one
target
one
pathway
respect
alkaloid
target
strongli
interconnect
manytomani
relationship
gener
overview
global
topolog
properti
network
obtain
statist
data
network
analyz
cytoscap
diamet
network
central
densiti
node
degre
indic
number
edg
link
node
highli
connect
node
refer
hub
network
degre
alkaloid
fig
import
target
fig
investig
compound
higher
degre
valu
might
particip
interact
compon
hub
network
target
degre
valu
mostli
rang
target
highest
degre
valu
includ
mif
ttr
fabz
mr
target
higher
degre
valu
might
involv
pharmacolog
action
cordata
extract
purifi
alkaloid
cordata
exhibit
notabl
activ
staphylococcu
aureu
pseudomona
aeruginosa
escherichia
coli
bacillu
subtili
tetracoccu
spp
methicillinresist
staphylococcu
aureu
mrsa
studi
propos
target
close
relat
microorgan
seven
exhibit
antibacteri
activ
fig
key
type
alkaloid
antibacteri
activ
dihydrobenzo
c
phenanthridin
alkaloid
protoberberin
five
target
lmrr
cat
fnr
actr
relat
multidrugresist
bacteri
strain
lmrr
multidrug
bind
transcript
regul
predict
target
padrrel
transcript
repressor
regul
product
lmrcd
major
multidrug
abc
transport
lactococcu
lacti
betalactamas
fish
one
antibioticresist
determin
penicillin
earli
cephalosporin
novel
drug
deriv
new
drug
innov
astrazeneca
inhibitor
alreadi
enter
phase
iii
clinic
develop
addit
chloramphenicol
acetyltransferas
cat
antibioticinactiv
enzym
predict
catalyz
acetylscoadepend
acetyl
chloramphenicol
group
result
chloramphenicolresist
bacteria
ferredoxinnadp
reductas
fnr
target
silico
particip
numer
electron
transfer
reaction
homolog
enzym
human
target
accumul
multidrugresist
microbi
strain
streptomyc
coelicolor
tetr
famili
protein
actr
found
actr
may
mediat
time
selfresist
endogenouslyproduc
antibiot
tetrmedi
antibioticresist
might
acquir
antibioticproduc
organ
two
target
indic
pathway
involv
antibacteri
activ
zipaftsz
complex
fish
fig
zipa
membraneanchor
protein
e
coli
interact
ftszmediat
bacteri
cell
divis
consid
potenti
target
antibacteri
agent
target
enr
catalyz
essenti
step
fatti
acid
biosynthesi
enr
target
narrowspectrum
antibacteri
drug
discoveri
essenti
role
metabol
sequenc
conserv
across
mani
bacteri
speci
cordata
show
remark
effect
ichthyophthiriu
multifilii
grass
carp
richadsin
well
dactylogyru
intermediu
carassiu
auratu
total
alkaloid
cordata
abl
kill
gastrointestin
parasit
studi
five
target
involv
parasit
diseas
predict
lack
report
crystal
structur
parasitosi
five
target
relat
parasitosi
either
human
anim
howev
find
suggest
potenti
mcordata
treat
parasitosi
malaria
chaga
diseas
kalaazar
enoylacyl
carrier
reductas
pfenr
fish
two
alkaloid
hydroxymyristoyl
acyl
carrier
protein
dehydratas
fabz
silico
target
six
alkaloid
involv
fatti
acid
biosynthesi
plasmodium
falciparum
antioxid
enzym
gr
fish
target
antimalari
drug
develop
target
glycosom
dehydrogenas
gapdh
found
target
develop
novel
chemotherapeut
agent
treatment
chaga
diseas
dihydroorot
dehydrogenas
dhodh
retriev
relat
leishmania
infect
trypanosoma
infect
mixtur
isoquinolin
alkaloid
cordata
exhibit
strong
analges
activ
toward
pain
caus
inflammatori
cytokin
direct
peripher
nerv
stimul
studi
three
target
relat
pain
identifi
abundantli
express
central
peripher
nervou
system
involv
subchron
pain
inflamm
profil
result
pick
five
alkaloid
mapk
fish
involv
develop
mainten
inflammatori
pain
reductas
alr
fish
specif
target
pain
diabet
neuropathi
inhibitor
alr
reliev
pain
improv
somat
autonom
nerv
function
addit
base
action
network
berberin
ber
may
also
involv
analges
activ
cordata
eight
target
relat
inflamm
identifi
studi
catalyt
subunit
gamma
isoform
fish
recruit
leukocyt
proteinas
also
known
macrophag
metalloelastas
mme
macrophag
elastas
identifi
three
fit
compound
studi
mediat
neutrophil
macrophag
recruit
cell
polar
potenti
therapeut
target
asthma
fish
anoth
inflammationrel
target
earli
find
demonstr
antiinflammatori
effect
activ
human
murin
monocytesmacrophag
monocytemacrophag
cell
line
mapk
involv
signal
cascad
control
cellular
respons
inflammatori
cytokin
verifi
pathway
murin
macrophag
cell
cordata
extract
increas
mrna
protein
level
cytoprotect
enzym
includ
heme
thioredoxin
via
activ
pathway
kinas
calciumcalmodulindepend
protein
kinas
ii
camkii
regul
intracellular
level
trigger
activ
transcript
factor
nuclear
factorkappa
b
tcell
receptor
stimul
inhibitori
effect
camkii
confirm
phospholipas
key
enzym
prostaglandin
pg
biosynthesi
discharg
arachidon
acid
select
inhibitor
implic
inflamm
connect
divers
diseas
cancer
ischemia
atherosclerosi
schizophrenia
target
mineralocorticoid
receptor
mr
fish
five
compound
activ
mineralocorticoid
aldosteron
deoxycorticosteron
well
glucocorticoid
like
cortisol
antagonist
mr
cardioprotect
antiinflammatori
effect
vivo
via
aldosteroneindepend
mechan
macrophag
migrat
inhibitori
factor
mif
involv
innat
adapt
immun
respons
inhibitor
mif
potenti
antiinflammatori
agent
seven
eight
predict
target
also
relat
cancer
dual
correl
target
mapk
camkii
mif
match
compound
shown
fig
benzo
c
phenanthridin
ben
alkaloid
berberin
ber
alkaloid
involv
antiinflammatori
activ
studi
four
predict
target
mr
comp
involv
injuri
repair
among
mr
link
intern
injuri
brain
injuri
vascular
injuri
neuron
injuri
target
cartilag
oligomer
matrix
protein
comp
found
noncollagen
extracellular
matrix
protein
found
predominantli
cartilag
also
tendon
ligament
meniscu
comp
marker
joint
destruct
associ
osteoarthr
rheumatoid
arthriti
trauma
intens
activ
mix
singl
alkaloid
cordata
strongli
inhibit
prolifer
induc
apoptosi
cancer
cell
anticanc
drug
isoquinolin
type
major
compon
chelidonin
sanguinarin
chelerythrin
protopin
allocryptopin
exert
cytotox
effect
cancer
cell
without
neg
effect
normal
cell
radiosensit
effect
cancer
cell
exert
radioprotect
effect
normal
cell
pharmacolog
profil
result
almost
half
predict
target
target
close
relationship
cancer
ten
tabl
success
enter
clinic
trial
observ
total
nine
target
relat
cancer
fish
five
compound
result
reveal
promis
prospect
cordata
antitumor
drug
research
develop
base
action
network
fig
possibl
antitumor
molecular
mechan
mcordata
analyz
follow
possibl
effect
target
like
contribut
compound
mif
column
particularli
tall
fig
fish
compound
includ
quaternari
benzo
c
phenanthridin
ben
alkaloid
two
benzo
c
phenanthridin
ben
alkaloid
five
protoberberin
ber
alkaloid
two
protopin
pro
alkaloid
discov
pathway
compound
mainli
includ
erk
signal
pathway
baxbcl
caspasedepend
pathway
rosmedi
mitochondri
pathway
pathway
vegfinduc
akt
phosphoryl
pathway
pathway
link
close
mif
howev
experiment
report
interact
mif
alkaloid
transthyretin
ttr
protooncogen
serin
threonin
kinas
found
seven
compound
ttr
biomark
lung
cancer
pancreat
ductal
adenocarcinoma
yet
confirm
therapeut
target
fish
also
verifi
hypodb
screen
respons
cell
cycl
regul
antiapoptot
activ
mediat
home
migrat
receptor
tyrosin
kinas
via
jakstat
pathway
upregul
mani
hematolog
malign
solid
tumor
although
pim
kinas
describ
weak
oncogen
heavili
target
anticanc
drug
discoveri
partial
involv
jakstat
pathway
benzo
c
phenanthridin
ben
alkaloid
cordata
hit
cancerrel
target
total
time
compar
time
protoberberin
ber
five
time
protopin
pro
one
time
bisbenzo
c
phenanthridin
bisben
fig
accord
quantit
determin
alkaloid
cordata
quaternari
benzo
c
phenanthridin
alkaloid
main
activ
compon
howev
dihydrobenzo
c
phenanthridin
rare
reach
limit
detect
lod
hit
target
main
alkaloid
quaternari
dihydrobenzo
c
phenanthridin
transform
one
anoth
dihydrobenzo
c
phenanthridin
could
activ
compound
vivo
metabol
examin
pig
liver
microsom
cytosol
electrospray
ioniz
hybrid
ion
traptimeofflight
mass
spectrometri
one
main
metabolit
liver
microsom
metabolit
cytosol
henc
issu
whether
dihydrobenzo
c
phenanthridin
main
compound
combin
target
vivo
requir
investig
among
cancerrel
target
least
seven
includ
mif
camkii
involv
immun
system
immuneassoci
target
might
crucial
oncotherapi
cordata
accord
pharmacolog
profil
unreport
pharmacolog
perform
mcordata
emerg
studi
target
link
neurodegener
fish
among
ach
maob
crucial
therapeut
target
alzheim
diseas
parkinson
diseas
addit
antivir
activ
especi
antihiv
antisar
coronaviru
antifung
activ
kind
extens
antibacteri
function
cordata
possibl
antihiv
activ
notabl
revers
transcriptas
multidrugresist
proteas
particularli
relat
aid
meanwhil
antihiv
activ
partli
confirm
hypodb
screen
protein
sarscov
pro
predict
attract
target
structurebas
drug
design
antisar
drug
owe
indispens
matur
sever
acut
respiratori
syndrom
coronaviru
sarscov
anoth
target
pol
fish
five
alkaloid
target
antihcv
therapeut
advanc
inhibitor
pol
would
princip
option
treatment
hcv
meanwhil
scytalon
dehydratas
neg
transcript
regul
nmra
suggest
physiolog
target
new
fungicid
subject
inhibitor
design
optim
paper
propos
wide
rang
promis
target
isoquinolin
alkaloid
cordata
hit
yet
proven
pharmacolog
experi
silicotarget
fish
anticanc
antiinflammatori
analges
effect
cordata
signific
among
mani
possibl
activ
possibl
anticanc
effect
mainli
contribut
isoquinolin
alkaloid
activ
compon
